SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-04-035154
Filing Date
2004-11-12
Accepted
2004-11-12 06:21:45
Documents
10
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a04-12837_110q.htm 10-Q 466878
2 EX-10.1 a04-12837_1ex10d1.htm EX-10.1 131373
3 EX-10.2 a04-12837_1ex10d2.htm EX-10.2 65156
4 EX-10.3 a04-12837_1ex10d3.htm EX-10.3 38835
5 EX-10.4 a04-12837_1ex10d4.htm EX-10.4 45925
6 EX-10.5 a04-12837_1ex10d5.htm EX-10.5 94402
7 EX-31.1 a04-12837_1ex31d1.htm EX-31.1 9720
8 EX-31.2 a04-12837_1ex31d2.htm EX-31.2 9733
9 EX-32.1 a04-12837_1ex32d1.htm EX-32.1 7151
10 EX-32.2 a04-12837_1ex32d2.htm EX-32.2 7184
  Complete submission text file 0001104659-04-035154.txt   878977
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26372 | Film No.: 041134913
SIC: 2834 Pharmaceutical Preparations